Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 3284 entries
View as:

A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06271837 Org: User:
Start: 02/18/24 End: 04/01/27 Due: 04/01/28

RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT06491862 Org: User:
Start: 07/25/24 End: 06/30/25 Due: 06/30/26

Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France

Phase: N/A Priority: Normal
NCT ID: NCT00681837 Org: User:
Start: 05/31/08 End: 09/30/08 Due: 09/30/09

A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05221840 Org: User:
Start: 02/07/22 End: 05/31/30 Due: 05/31/31

Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03706079 Org: User:
Start: 01/07/19 End: 05/18/22 Due: 05/18/23

Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT06432764 Org: User:
Start: 10/16/24 End: 08/14/26 Due: 08/14/27

Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI

Phase: N/A Priority: Normal
NCT ID: NCT01005251 Org: User:
Start: 10/31/09 End: 07/31/10 Due: 07/31/11

Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01619059 Org: User:
Start: 06/30/12 End: 01/31/15 Due: 01/31/16

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT06355934 Org: User:
Start: 08/21/23 End: 09/30/26 Due: 09/30/27

Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06514157 Org: User:
Start: 08/19/24 End: 09/09/24 Due: 09/09/25

A Study in Patients With Myasthenia Gravis in China

Phase: N/A Priority: Normal
NCT ID: NCT06700616 Org: User:
Start: 09/26/24 End: 12/30/27 Due: 12/30/28

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT06097728 Org: User:
Start: 11/09/23 End: 03/13/28 Due: 03/13/29

An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab

Phase: N/A Priority: Normal
NCT ID: NCT06908577 Org: User:
Start: 04/07/25 End: 11/12/25 Due: 11/12/26

14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations

Phase: N/A Priority: Normal
NCT ID: NCT00813306 Org: User:
Start: 12/31/08 End: 11/30/09 Due: 11/30/10

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

Phase: N/A Priority: Normal
NCT ID: NCT00653744 Org: User:
Start: 03/31/02 End: 03/31/04 Due: 03/31/05

A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02546323 Org: User:
Start: 09/17/15 End: 01/29/19 Due: 01/29/20

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Phase: N/A Priority: Normal
NCT ID: NCT05648110 Org: User:
Start: 12/16/22 End: 02/11/25 Due: 02/11/26

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05251259 Org: User:
Start: 01/27/22 End: 01/29/26 Due: 01/29/27

Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Phase: N/A Priority: Normal
NCT ID: NCT01086293 Org: User:
Start: 01/31/10 End: 12/31/15 Due: 12/31/16

A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study

Phase: N/A Priority: Normal
NCT ID: NCT01254721 Org: User:
Start: 12/31/10 End: 10/31/12 Due: 10/31/13

China Survey of Peptic Ulcer Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT01241266 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject

Phase: N/A Priority: Normal
NCT ID: NCT01161355 Org: User:
Start: 06/30/10 End: 06/30/10 Due: 06/30/11

EXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (MITOS: EROS+CP US Study)

Phase: N/A Priority: Normal
NCT ID: NCT06742736 Org: User:
Start: 05/31/24 End: 09/30/24 Due: 09/30/25

A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients Who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)

Phase: N/A Priority: Normal
NCT ID: NCT06744374 Org: User:
Start: 02/29/24 End: 03/30/24 Due: 03/30/25

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Phase: N/A Priority: Normal
NCT ID: NCT06219941 Org: User:
Start: 12/13/23 End: 12/31/26 Due: 12/31/27